UFP Technologies, Inc. $UFPT Shares Acquired by Renaissance Group LLC

Renaissance Group LLC increased its position in shares of UFP Technologies, Inc. (NASDAQ:UFPT) by 31.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,565 shares of the industrial products company’s stock after purchasing an additional 6,820 shares during the quarter. Renaissance Group LLC’s holdings in UFP Technologies were worth $6,974,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in UFPT. Nisa Investment Advisors LLC raised its holdings in shares of UFP Technologies by 290.3% during the second quarter. Nisa Investment Advisors LLC now owns 121 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 90 shares during the period. PNC Financial Services Group Inc. lifted its holdings in UFP Technologies by 179.0% in the second quarter. PNC Financial Services Group Inc. now owns 173 shares of the industrial products company’s stock worth $42,000 after acquiring an additional 111 shares during the last quarter. GAMMA Investing LLC boosted its stake in UFP Technologies by 37.6% in the second quarter. GAMMA Investing LLC now owns 183 shares of the industrial products company’s stock valued at $45,000 after acquiring an additional 50 shares during the period. State of Wyoming grew its holdings in shares of UFP Technologies by 34.7% during the first quarter. State of Wyoming now owns 365 shares of the industrial products company’s stock valued at $74,000 after purchasing an additional 94 shares during the last quarter. Finally, Jones Financial Companies Lllp acquired a new stake in shares of UFP Technologies during the 1st quarter worth approximately $172,000. Institutional investors own 87.28% of the company’s stock.

Insider Activity

In other news, SVP Christopher P. Litterio sold 1,829 shares of UFP Technologies stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $227.20, for a total transaction of $415,548.80. Following the transaction, the senior vice president directly owned 10,756 shares in the company, valued at approximately $2,443,763.20. This trade represents a 14.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 4.40% of the company’s stock.

Analyst Ratings Changes

UFPT has been the subject of several analyst reports. Lake Street Capital boosted their price target on shares of UFP Technologies from $252.00 to $289.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Weiss Ratings reissued a “hold (c)” rating on shares of UFP Technologies in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, UFP Technologies presently has an average rating of “Hold” and an average price target of $289.00.

UFP Technologies Stock Down 1.9%

UFP Technologies stock opened at $218.58 on Wednesday. The company’s 50-day moving average price is $204.58 and its two-hundred day moving average price is $221.86. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 25.33 and a beta of 1.16. UFP Technologies, Inc. has a 52 week low of $178.26 and a 52 week high of $327.68. The company has a current ratio of 2.77, a quick ratio of 1.53 and a debt-to-equity ratio of 0.39.

UFP Technologies (NASDAQ:UFPT) last posted its quarterly earnings data on Thursday, November 9th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter. UFP Technologies had a net margin of 11.40% and a return on equity of 21.54%. The business had revenue of $96.97 million during the quarter.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.